James A. Kaye
Impact in
- Hematology top 0.5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Oncology top 2%
- Neutropenia and Cancer Infections
Papers in
- Hematology 31
- Chronic Myeloid Leukemia Treatments 9
- Oncology 71
- Neutropenia and Cancer Infections 11
- Co-authors
- Hershel JickSusan S. JickCorri BlackStefan RussmannLuis A. Garcı́a Rodrı́guezCatherine Vasilakis‐ScaramozzaChristoph MeierRaymond G. Schlienger
- Journals
- Value in Health (20 papers)Blood (7 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (6 papers)Journal of Clinical Oncology (6 papers)Sarcoma (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James A. Kaye
163 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Hematology 1.1k
- Oncology 1.2k
- Genetics 408
- Cancer Research 569
- Gastroenterology 205
Countries citing papers authored by James A. Kaye
This map shows the geographic impact of James A. Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Kaye more than expected).
Fields of papers citing papers by James A. Kaye
This network shows the impact of papers produced by James A. Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Kaye. The network helps show where James A. Kaye may publish in the future.
Co-authors
The 25 scholars most cited alongside James A. Kaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 18 | |
| 2 | 2021 | 19 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 8 | |
| 5 | 2019 | 16 | |
| 6 | 2019 | 31 | |
| 7 | 2019 | 10 | |
| 8 | 2018 | 37 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 14 | |
| 11 | 2017 | 19 | |
| 12 | 2017 | 11 | |
| 13 | 2014 | 1 | |
| 14 | 2011 | 25 | |
| 15 | The REMS publication paradox. | 2009 | 3 |
| 16 | 2005 | 51 | |
| 17 | Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK. | 2004 | 32 |
| 18 | 2002 | 14 | |
| 19 | 2000 | 39 | |
| 20 | Peripheral vascular disease in Johannesburg. An analysis of 269 peripheral arteriograms performed at the Johannesburg General Hospital. | 1963 | 1 |
About James A. Kaye
James A. Kaye is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Internal Medicine, having authored 169 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (13 papers), Neutropenia and Cancer Infections (11 papers), Advanced Breast Cancer Therapies (10 papers), Gastric Cancer Management and Outcomes (9 papers), Sarcoma Diagnosis and Treatment (9 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (1.2k citations), Genetics (408 citations), Cancer Research (569 citations) and Gastroenterology (205 citations). James A. Kaye has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hershel Jick, Susan S. Jick, Corri Black, Stefan Russmann, Luis A. Garcı́a Rodrı́guez, Catherine Vasilakis‐Scaramozza, Christoph Meier, Raymond G. Schlienger, Ana Ruigómez and Keith L. Davis. Their work appears in journals such as Value in Health, Blood, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Clinical Oncology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.